Villalona-Calero MA - Search Results

1

Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells.

Duan W, Gao L, Wu X, Zhang Y, Otterson GA, Villalona-Calero MA. Duan W, et al. Exp Cell Res. 2006 Oct 15;312(17):3370-8. doi: 10.1016/j.yexcr.2006.07.005. Epub 2006 Jul 21. Exp Cell Res. 2006. PMID: 16934800

2

Targeted Therapies in Early-Stage Resectable Non-Small-Cell Lung Cancer: New Kids on the Block.

Liu J, Amini A, Govindarajan A, Abuali T, Mambetsariev I, Massarelli E, Villaflor V, Villalona-Calero M, West H, Williams T, Salgia R. Liu J, et al. JCO Precis Oncol. 2023 Sep;7:e2200445. doi: 10.1200/PO.22.00445. JCO Precis Oncol. 2023. PMID: 37656950 Review.

3

Acute progranulocytic leukemia (APL): possible in vivo differentiation by granulocyte colony-stimulating factor (G-CSF).

Vaickus L, Villalona-Calero MA, Caligiuri T. Vaickus L, et al. Leukemia. 1993 Oct;7(10):1680-1. Leukemia. 1993. PMID: 7692195 No abstract available.

4

Integrating Early-Stage Drug Development with Clinical Networks; Challenges and Opportunities: The City of Hope Developing Experience.

Villalona-Calero MA, Malhotra J, Chung V, Xing Y, Gray SW, Hampel H, Gruber S, McDonnell K. Villalona-Calero MA, et al. J Clin Med. 2023 Jun 15;12(12):4061. doi: 10.3390/jcm12124061. J Clin Med. 2023. PMID: 37373756 Free PMC article.

5

Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.

Zhu WG, Dai Z, Ding H, Srinivasan K, Hall J, Duan W, Villalona-Calero MA, Plass C, Otterson GA. Zhu WG, et al. Oncogene. 2001 Nov 22;20(53):7787-96. doi: 10.1038/sj.onc.1204970. Oncogene. 2001. PMID: 11753657

6

Pharmacobiologically based scheduling of capecitabine and docetaxel results in antitumor activity in resistant human malignancies.

Nadella P, Shapiro C, Otterson GA, Hauger M, Erdal S, Kraut E, Clinton S, Shah M, Stanek M, Monk P, Villalona-Calero MA. Nadella P, et al. J Clin Oncol. 2002 Jun 1;20(11):2616-23. doi: 10.1200/JCO.2002.22.030. J Clin Oncol. 2002. PMID: 12039922 Clinical Trial.

7

A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer.

Rudin CM, Otterson GA, Mauer AM, Villalona-Calero MA, Tomek R, Prange B, George CM, Szeto L, Vokes EE. Rudin CM, et al. Ann Oncol. 2002 Apr;13(4):539-45. doi: 10.1093/annonc/mdf124. Ann Oncol. 2002. PMID: 12056703 Free article. Clinical Trial.

8

RT-PCR heteroduplex analysis permits differentiation of transgene and host gene expression in a transgenic animal model.

Duan W, Ding H, Zhu WG, Srinivasan K, Otterson GA, Villalona-Calero MA, Ottersom GA. Duan W, et al. Biotechniques. 2002 Jul;33(1):58, 60-2, 64 passim. doi: 10.2144/02331st02. Biotechniques. 2002. PMID: 12139258 Free article.

9

Lung-specific expression of human mutant p53-273H is associated with a high frequency of lung adenocarcinoma in transgenic mice.

Duan W, Ding H, Subler MA, Zhu WG, Zhang H, Stoner GD, Windle JJ, Otterson GA, Villalona-Calero MA. Duan W, et al. Oncogene. 2002 Nov 7;21(51):7831-8. doi: 10.1038/sj.onc.1205909. Oncogene. 2002. PMID: 12420220

10

P21 response to DNA damage induced by genistein and etoposide in human lung cancer cells.

Ding H, Duan W, Zhu WG, Ju R, Srinivasan K, Otterson GA, Villalona-Calero MA. Ding H, et al. Biochem Biophys Res Commun. 2003 Jun 13;305(4):950-6. doi: 10.1016/s0006-291x(03)00873-8. Biochem Biophys Res Commun. 2003. PMID: 12767922

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134 results

Search Page

Filters